Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 17/20 | 0.55 |
| ▸ | KDR | P35968 | 4/20 | 0.54 |
| ▸ | MST1R | Q04912 | 2/20 | 0.54 |
| ▸ | AXL | P30530 | 5/20 | 0.53 |
| ▸ | KIT | P10721 | 1/20 | 0.51 |
| ▸ | FLT4 | P35916 | 1/20 | 0.51 |
| ▸ | FLT3 | P36888 | 1/20 | 0.51 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3914919 | 0.82 | MET (0.56) | METKDRMST1RAXLKIT | |
| SCHEMBL3913410 | 0.76 | MET (0.61) | METKDRMST1RAXLPDGFRA | |
| SCHEMBL22923853 | 0.74 | AXL (0.68) | METKDRMST1RAXLKIT | |
| SCHEMBL3922913 | 0.74 | MET (0.64) | METKDRMST1RAXL | |
| SCHEMBL5824355 | 0.74 | MET (0.70) | METKDRMST1RAXLKIT | |
| SCHEMBL3921647 | 0.74 | AXL (0.62) | METKDRAXLKITPDGFRA | |
| SCHEMBL5301510 | 0.73 | MET (0.44) | METKDRAXL | |
| SCHEMBL3913677 | 0.73 | MET (0.65) | METAXL | |
| SCHEMBL31412937 | 0.72 | MET (0.60) | METKDRMST1RAXLKIT | |
| SCHEMBL31412928 | 0.72 | MET (0.75) | METKDRMST1RAXLKIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2032538-A2 | QUINOLINE COMPOUNDS AND METHODS OF USE | Array Biopharma, Inc. (US) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007146824-A2 | QUINOLINE COMPOUNDS AND METHODS OF USE | ARRAY BIOPHARMA INC. (US) | 2007-12-21 | — | — | WO | disclosed |